Histopathologic pattern and molecular risk stratification are associated with prognosis in patients with stage IB lung adenocarcinoma.

In our study, we observed that the EGFR -mutant patients showed a trend of better DFS when treated with TKIs than other adjuvant therapies ( Figure S2B ); however, this difference was not significant due to the sample size and short follow-up period.

also in 53,322 other papers